The CORE Institute adds Dr. Norman Payson to board of directors — 5 observations

Phoenix-based The CORE Institute named Norman C. Payson, MD, to its board of directors.

Advertisement

Here are five things to know:

 

1. Dr. Payson has had a 30-plus year career that included CEO and chairman roles with several organizations.

 

2. He co-founded Chicago-based Healthsource and served as its CEO, was CEO of Trumbull, Conn.-based Oxford Health Plans’ insurance business, Chairman of Addison, Texas-based Concentra and CEO of Lake Forest, Calif.-based Apria Healthcare.

 

3. The CORE Institute Chairman and Founder David Jacofsky, MD, said, “[Dr. Payson] is among the most well-respected minds in the business of insurance anywhere in the world, and is both a physician and a national name in business which provides him a unique perspective from both vantage points.”

 

4. Dr. Payson has served as a sponsor and mentor at Boston-based MIT’s Health Sciences Technology Division’s Biomedical Enterprise Program. He lectures at Hanover, N.H.-based Dartmouth Geisel School of Medicine and Tuck School of Business.

 

5. Dr. Payson’s appointment is in collaboration with Phoenix-based Excellence Headquarters, The CORE Institute’s management company.

 

More articles on practice management:
NewYork-Presbyterian, Weill Cornell Medicine establish rehabilitation medicine department; Dr. Joel Stein to chair — 6 notes

Hoag Orthopedic Institute releases annual report: 7 things to know

Oregon Democrats file ethics complaint against Rep. Dr. Knute Buehler over undisclosed Stryker, Pfizer payments

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Practice Management

Advertisement

Comments are closed.